Methotrexate |
| Katalog-Nr.GC10405 |
Methotrexat, ein Folsäureantagonist, ist ein wirksames entzündungshemmendes Mittel, wenn es wöchentlich in niedrigen Konzentrationen angewendet wird. Die antiphlogistische Wirkung beruht auf einer erhöhten Freisetzung von Adenosin an entzündeten Stellen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 59-05-2
Sample solution is provided at 25 µL, 10mM.
Methotrexate is an antifolate antimetabolite that effectively inhibits the activity of dihydrofolate reductase (DHFR), with an IC50 of approximately 7nM [1]. Folic acid is essential for the biosynthesis of purine and pyrimidine bases, so methotrexate interferes with the synthesis of purines and pyrimidines required for DNA replication and cell proliferation [2]. Methotrexate also inhibits adenosine deaminase (ADA), resulting in increased extracellular adenine nucleotide levels [3]. Methotrexate has anticancer, antirheumatic, anti-inflammatory and immunomodulatory activities [4].
In vitro, methotrexate (5 μg/ml) has a wide range of IC50s against various cancer cell lines, from 6.05±0.81 nM to >1,000 nM. Methotrexate resistance in Saos-2 and MCF-7 cells The most potent, AGS and HCT-116 cells are highly sensitive to methotrexate, with IC50 of 6.05±0.81nM and 13.56±3.76nM respectively. NCI-H23 and A549 cells show similar sensitivity to methotrexate [5]. Methotrexate (3ng/ml-1μg/ml) measured the degree of drug resistance of the U-2OS cell line and found that the cell resistance was related to the increase in intracellular DHFR levels [6].
In vivo, treatment of arthritic DBA/1J mice with methotrexate (2-50 mg/kg; s.c.) dose-dependently reduced disease activity and mean paw volume and increased mean body weight percentage [7]. Methotrexate (2 mg/kg; i.p.) treats arthritis in rats and has significant anti-arthritic effects and prevents the occurrence of hematological toxicity [8].
References:
[1]Gurdag S, Khandare J, Stapels S, et al. Activity of dendrimer−methotrexate conjugates on methotrexate-sensitive and-resistant cell lines[J]. Bioconjugate chemistry, 2006, 17(2): 275-283.
[2] Rajagopalan P T R , Zhang Z , Mccourt L ,et al.Interaction of dihydrofolate reductase with methotrexate: Ensemble and single-molecule kinetics[J].Proceedings of the National Academy of Sciences, 2002, 99(21):13481-13486.
[3] Sramek M, Neradil J, Veselska R. Much more than you expected: the non-DHFR-mediated effects of methotrexate[J]. Biochimica et Biophysica Acta (BBA)-General Subjects, 2017, 1861(3): 499-503.
[4] Bedoui Y, Guillot X, Sélambarom J, et al. Methotrexate an old drug with new tricks[J]. International journal of molecular sciences, 2019, 20(20): 5023.
[5] Yoon S A , Choi J R , Kim J O ,et al. Influence of Reduced Folate Carrier and Dihydrofolate Reductase Genes on Methotrexate-Induced Cytotoxicity[J].Cancer Research & Treatment, 2010, 42(3):163-171.
[6]Serra M , Reverter B G , Maurici D ,et al.Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.[J].Annals of oncology, 2004.
[7] Singh, Rakesh K.van Haandel, LeonKiptoo, et al . Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model[J].European Journal of Pharmacology: An International Journal, 2019, 853.
[8] Banji D , Banji O F , Reddy K , et al. Evaluation of the concomitant use of methotrexate and curcumin on Freund's complete adjuvant-induced arthritis and hematological indices in rats[J]. Indian Journal of Pharmacology, 2011, 43(5):546-550.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *